Concepedia

Thomas Littlejohn

TL

Statistics

Publications

35

Citations

1.8K

H-Index

24

Active since

1996

Affiliations

Medical Research Associates(Current)

Daiichi Sankyo (United States)

Christ Hospital

University of Oklahoma

University at Buffalo, State University of New York

Thomas Littlejohn is an author at Medical Research Associates specializing in pharmacology, pharmacotherapy, and clinical pharmacology.

Publications per year

1996–2012

35

Publications

35

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Daniel M. Bloomfield, Gary L. Carlson, Aditi Sapre et al. · American Heart Journal · 2008 · 244 citations

, , +12

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.

Mark P. Ettinger, Thomas Littlejohn, Sherwyn Schwartz et al. · PubMed · 2003 · 206 citations

, , +16

MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin

Harold Bays, Sherwyn Schwartz, Thomas Littlejohn et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 148 citations · Full text

, , +17

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: A double-blind, phase II multicenter trial

Jerry Bagel, W. Thomas Garland, Debra Breneman et al. · Journal of the American Academy of Dermatology · 1998 · 97 citations

, , +5

Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients

Thomas Littlejohn, Claudio Majul, Rafael Olvera et al. · Journal of Clinical Hypertension · 2009 · 96 citations · Full text

, , +16

1–5 of 35